News

ImmunoGen, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for IMGN632 for the treatment of patients with relapsed or…
Read More...

GlycoMimetics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted the Company a Rare Pediatric Disease designation for rivipansel for the treatment of sickle…
Read More...

Eureka Therapeutics, Inc., a clinical stage biotechnology company developing novel T cell therapies to treat solid tumors, today announced the Company has initiated a Phase I/II…
Read More...

SpringWorks Therapeutics, Inc. announced that the company has entered into a clinical trial collaboration agreement with Pfizer Inc. (NYSE: PFE) to evaluate SpringWorks Therapeutics’…
Read More...

Nimble Therapeutics Inc. announced the company has entered into a strategic collaboration with Incyte to discover first-in-class peptide therapies across various disease areas. “This…
Read More...

Bristol Myers Squibb and MyoKardia, Inc. announced a definitive merger agreement under which Bristol Myers Squibb will acquire MyoKardia for $13.1 billion, or $225.00 per share in cash.…
Read More...

NVIDIA announced a partnership with global healthcare company GSK and its AI group, which is applying computation to the drug and vaccine discovery process. GSK has recently…
Read More...

BONE THERAPEUTICS, the cell therapy company addressing unmet medical needs in orthopedics and other diseases, Link Health Pharma Co., Ltd and Shenzhen Pregene Biopharma Company, Ltd…
Read More...

Bristol Myers Squibb announced that Opdivo (nivolumab) 360 mg every three weeks plus Yervoy (ipilimumab) 1 mg/kg every six weeks (injections for intravenous use) was approved by the…
Read More...

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of Alcami’s Germantown, Wisconsin facility in the US. The…
Read More...

Siegfried has signed binding agreements with Novartis regarding the acquisition of two pharmaceutical manufacturing sites in Spain. With this acquisition, Siegfried will significantly…
Read More...

Pfizer Inc. announced that its investigational gene therapy candidate (PF-06939926) being developed to treat Duchenne muscular dystrophy (DMD) received Fast Track designation from the…
Read More...

FUJIFILM Corporation announces the conclusion of a manufacturing contract agreement with biotechnology company, VLP Therapeutics Japan LLC (Representative Executor: Wataru Akahata,…
Read More...

Lonza Bioscience has announced today the commercial release of the PyroCell MAT System, a sustainable and reliable solution for in vitro pyrogen testing. The new offering expands upon…
Read More...

Catalent announced the launch of its new OneXpress service for the integrated development, scale up and manufacturing of new oral solid dosage forms. The OneXpress solution…
Read More...

Alnylam Pharmaceuticals, Inc. announced positive topline results from the ILLUMINATE-B pediatric Phase 3 study of lumasiran, an investigational RNAi therapeutic targeting hydroxyacid…
Read More...

Covis Group S.à r.l. and AMAG Pharmaceuticals, Inc. announced that they have entered into a definitive agreement under which Covis will acquire AMAG for $13.75 per share in cash, or…
Read More...

ViralClear Pharmaceuticals, Inc. and Sorrento Therapeutics, Inc. announced the companies are exploring the synergistic potential of small molecules and antibodies combination therapies…
Read More...

Eisai Co., Ltd. and Seikagaku Corporation announced that the companies have entered into an agreement for the marketing alliance in South Korea for SI-613 (diclofenac conjugated sodium…
Read More...

Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company focused on the development of female oncology products in the precision medicine metastatic breast cancer…
Read More...